(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ: PACB) rose 8.81% to $5.68 at 12:16 EST on Thursday, after two sequential sessions in a row of losses. NASDAQ is jumping 0.05% to $11,424.13, following the last session’s downward trend. This seems, at the moment, a somewhat bullish trend trading session today.

Pacific Biosciences of California’s last close was $5.22, 85.64% below its 52-week high of $36.36.

Volume

Today’s last reported volume for Pacific Biosciences of California is 2092676 which is 66.68% below its average volume of 6280637.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 33.8% for the ongoing quarter and 48.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 178.4% and positive 40% for the next.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a positive 5.01%, a negative 1.50%, and a positive 5.90%, respectively.

Pacific Biosciences of California’s highest amplitude of average volatility was 9.00% (last week), 6.63% (last month), and 5.90% (last quarter), respectively.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.68 at 12:16 EST, way below its 52-week high of $36.36 and way above its 52-week low of $4.51.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way under its 50-day moving average of $8.33 and way under its 200-day moving average of $18.79.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here